De financiering zal worden gebruikt om de productie van OSCP’s ITAR-vrije fotonische IMU’s in Montréal op te schalen naarmate de vraag naar navigatie die ook werkt wanneer GNSS wordt verstoord, toeneemt.

MONTRÉAL, 1 oktober 2026 — OSCPS Motion Sensing Inc., handelend onder de naam OSCP, heeft vandaag aangekondigd dat het een door New Science Ventures geleide Series A-financiering heeft afgesloten, met deelname van Emerging Ventures en 2050 Capital. Somu Subramaniam, oprichter en managing partner van New Science Ventures, is toegetreden tot de raad van bestuur van OSCP.

De fotonische gyroscopen en inertiële meeteenheden (IMU’s) van OSCP zijn ontwikkeld voor platforms die moeten kunnen blijven navigeren wanneer GNSS-signalen worden verstoord, vervalst of niet beschikbaar zijn, een probleem dat inmiddels veel verder reikt dan officieel verklaarde conflictgebieden.

Het bedrijf zal de financiering gebruiken om de productie in Montréal op te schalen, zijn technische en verkoopteams uit te breiden en de volgende generatie fotonische inertiële sensoren op de markt te brengen.

“Het verlies van het satellietsignaal was vroeger een probleem op het slagveld. Nu doet het zich ook voor boven luchthavens en op scheepvaartroutes”, aldus Kazem Zandi, oprichter en CEO van OSCP. “Klanten willen navigatie waarop ze kunnen vertrouwen wanneer GNSS uitvalt, en ze willen dat die ITAR-vrij is. Deze financieringsronde stelt ons in staat om hier meer en sneller te produceren.”

“We zijn erg enthousiast om ons bij het team van OSCP aan te sluiten en ‘s werelds beste IMU’s te bouwen wat betreft navigatieprestaties, afmetingen en kosten. Deze IMU’s hebben het potentieel om het paradigma van autonome navigatie volledig te veranderen in een breed scala aan toepassingen in de defensie- en transportsector”, aldus Somu Subramaniam, oprichter en managing partner van New Science Ventures.

Sinds de financieringsronde in augustus werd afgesloten, heeft OSCP NavigationGate geïntroduceerd, een inertieel navigatiesysteem voor platforms die het satellietsignaal verliezen, ArduPilot-ondersteuning toegevoegd en een open-source ROS 2-driver voor zijn MK2-IMU-familie uitgebracht. Daarnaast is het bedrijf gekwalificeerd als leverancier voor Canada’s Defence Drone Initiative Marketplace. Zie voor meer informatie oscp.com.

OVER OSCP

OSCPS Motion Sensing Inc., handelend onder de naam OSCP, ontwerpt en produceert fotonische gyroscopen en inertiële meeteenheden. Het in 2015 opgerichte en in Montréal, Québec gevestigde bedrijf ontwikkelt inertiële sensoren die fotonische nauwkeurigheid van tactische kwaliteit bieden, met de afmetingen, het gewicht, het energieverbruik en de kosten van MEMS, voor navigatie in omgevingen waar GNSS wordt verstoord, gedegradeerd of niet beschikbaar is. De klanten van het bedrijf zijn actief in de ruimtevaart, defensie, op en onder zee, spoorwegen, robotica en autonome grondsystemen. OSCP-producten worden in Canada vervaardigd en zijn ITAR-vrij.

OVER NEW SCIENCE VENTURES

New Science Ventures is een durfkapitaalfonds dat investeert in ondernemingen die nieuwe wetenschappelijke benaderingen toepassen op het gebied van informatietechnologie en levenswetenschappen. De onderneming werd opgericht in 2004 en heeft kantoren in Greenwich, Connecticut, en Londen. Op basis van het oorspronkelijk toegezegde kapitaal heeft zij meer dan 1 miljard dollar aan beheerd vermogen. Ga voor meer informatie naar newscienceventures.com.

Mediacontact: [email protected]

Raised $540 Million in Equity over Last Five Years

DALLAS, Oct. 1, 2026 — NexBank Capital, Inc., a financial holding company and parent company of NexBank, today announced that it closed a $150 million capital raise through the sale of non-voting common stock on September 29, 2026. With this closing, the Company’s equity stock offerings have reached $540 million in aggregate since 2021.

NexBank Capital, Inc. intends to use the proceeds of the offering as growth capital and for other general corporate purposes. This capital raise allows the Company the financial flexibility to be opportunistic on its growth strategy.

Cantor Fitzgerald & Co. served as financial advisor in connection with $75 million of the capital raise. Hunton Andrews Kurth LLC served as legal counsel to NexBank Capital, Inc. in the offering.

This press release is for informational purposes only and shall not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor shall there be any sale of these securities in any jurisdiction in which such an offer or sale is not permitted.

About NexBank Capital, Inc.

NexBank Capital, Inc. is a Dallas-based financial holding company with $18 billion in assets. It provides financial and banking services primarily to institutional clients, financial institutions, corporations, and consumers nationwide. Through its subsidiary, NexBank, the largest privately held bank in Texas based on assets, it offers institutional banking, commercial banking, mortgage banking, and personal banking services.

www.NexBank.com

NexBank  |  Member FDIC  |  Equal Housing Lender

SOURCE NexBank Capital, Inc.

DANBURY, Conn., Oct. 1, 2026 — 108 BioCapital today announced that it is leading a financing round in SedMed, Inc. with a $4 million investment. The financing will support SedMed’s next phase of commercial growth and expand access to its non-electric toilet lift, which is designed to help older adults and individuals with mobility limitations sit and stand more safely and independently while reducing strain on caregivers.

SedMed is a medical device company developing non-electric mobility solutions that help older adults and individuals with limited mobility sit and stand more safely and independently while reducing physical strain on caregivers. Its flagship product, the SedMed Toilet Lift, attaches to most standard toilets and provides adjustable sit-to-stand assistance without electricity, batteries or bathroom remodeling.

“SedMed is addressing an important and often overlooked challenge for older adults, individuals with limited mobility and their caregivers,” said Sasha Bakhru, Managing Partner of 108 BioCapital. “The company has developed an intuitive, non-electric solution with the potential to improve safety, preserve independence and reduce caregiver burden across home and healthcare settings. We have been impressed by Jeremy and the SedMed team’s thoughtful approach to product development and commercialization, and we are pleased to lead this investment and support the company’s next phase of growth.”

SedMed will use the investment to accelerate commercial expansion, grow its distribution and channel partnerships, advance its intellectual property portfolio and conduct additional hospital-based studies.

“SedMed’s adoption across more than 40 hospital systems demonstrates strong demand for its solution and validates the important role it can play in addressing a significant challenge for healthcare providers,” said Shahryar Oveissi, General Partner of 108 BioCapital. “That momentum also sets the stage for SedMed to become a trusted solution for older adults living at home, where physical limitations, cognitive decline and environmental barriers can increase the risk of accidents and place added strain on caregivers.”

“SedMed’s practical, non-electric design gives the product meaningful potential beyond the United States,” said Shom Jagtiani, General Partner of 108 BioCapital. “We see particular opportunity in India and other international markets, where an easy-to-deploy solution could help improve bathroom safety and independence for older adults across home and healthcare settings.”

“This investment represents an important milestone for SedMed as we work to make safer bathroom mobility accessible to more people,” said Jeremy Bronen, CEO of SedMed. “108 BioCapital brings healthcare expertise and a shared commitment to supporting technologies that can meaningfully improve the lives of patients and caregivers. This funding will allow us to expand our commercial reach, strengthen our distribution network and build additional evidence demonstrating the value SedMed can provide to healthcare organizations.”

About SedMed, Inc.

SedMed, Inc. is a Milford, CT based medical device company developing reliable, non-electric mobility solutions that support bathroom safety, independence and dignity for older adults and individuals with limited mobility while reducing strain on caregivers. Its flagship SedMed Toilet Lift provides adjustable assistance for sitting and standing and is designed for use in homes, senior living communities and healthcare settings. For more information, visit https://sed-med.com/.

About 108 BioCapital

108 BioCapital is a U.S.-based private equity firm focused on growth-stage investments in biotech and medtech companies developing scalable, exit-driven solutions that address high-impact unmet medical needs. The firm also maintains a feeder vehicle in GIFT City, India. For more information, visit 108.bio.

Media Contacts

108 BioCapital
Steve Ward
Chief Financial Officer
[email protected]

SedMed, Inc.
[email protected]
(203) 538-9955
Sed-med.com

SOURCE 108 Bio Captial

Round will expand a unified AI platform spanning every patient touchpoint as Parakeet now serves six of the nation’s 10 largest dermatology groups

SAN FRANCISCO, Oct. 1, 2026 — Parakeet Health, a healthcare AI company transforming patient access, today announced an oversubscribed $10 million Series A led by Canvas Ventures, with participation from Blank Space Ventures, StoryHouse Ventures and HMC INQ. The round brings Parakeet’s total funding to $13 million.

The funding follows 10x annual recurring revenue growth over the past year, driven by measurable financial returns for customers. Parakeet helps healthcare organizations convert more patient demand into booked care, improve provider utilization and recover revenue lost across disconnected access workflows. The company has achieved that growth while maintaining a disciplined approach to capital.

Parakeet brings the ways patients communicate and complete actions throughout their care journey into one platform. It manages inbound calls, proactive outreach, fax processing and web scheduling across voice, SMS, email, web and fax. Because those capabilities operate together, a referral received by fax can move into patient outreach, scheduling and follow-up within the same workflow, with each action reflected in one performance dashboard. Healthcare organizations can replace multiple point solutions while giving patients a more consistent experience across every touchpoint.

Parakeet outperforms both legacy systems and the latest generation of healthcare voice AI. The platform emphasizes precision outbound patient communications, creating incremental revenue and capturing revenue leakage for its customers. A head-to-head pilot found that Parakeet’s inbound phone agent achieved 2.3 times the resolution rate of an established AI voice vendor.

“Patient engagement determines whether demand becomes care, whether clinical capacity is used and whether a healthcare organization grows,” said Jung Park, CEO and co-founder of Parakeet Health. “After years of operating and scaling healthcare organizations, I saw how often that value was lost across disconnected workflows, systems and vendors. We built Parakeet to connect the entire journey and produce a financial result leadership can measure. We have applied that same operator discipline to our own business, growing quickly while using capital efficiently.”

The platform integrates with existing EHR and practice-management systems and adapts to the requirements of each organization. It can navigate nuances among providers, procedures, locations, insurance, and scheduling rules, identify available clinical capacity and connect the appropriate patient with it. Parakeet is also advancing personalization across the platform. Each interaction can inform how, where and when to engage a patient next based on communication preferences, prior responses and care needs. That continuity is designed to increase the number of interactions completed without staff involvement, while making engagement more relevant to each patient.

Parakeet now works with six of the 10 largest dermatology groups in the country, supporting more than 2,800 providers across 1,100+ locations. The company is now rapidly expanding across other specialty and outpatient markets, including primary care, behavioral health, women’s health, eyecare, physical therapy, gastroenterology, and radiology. It also recently announced a national collaboration with Qualderm Partners, which supports nearly 160 practices across 17 states. Compared to leading patient-engagement vendors, Parakeet rebooks no-show patients at up to 4.9x higher rates and rebooks canceled patients at up to 4.2x higher rates across its deployments.

“Parakeet helps us get our Schweiger Dermatology and Schweiger Allergy & Asthma patients appointments when they need them,” said Julie Gessin, Chief Operating Officer at Schweiger Dermatology Group.

Parakeet’s operating model extends beyond just the technology. The company works with healthcare leadership teams to model potential EBITDA impact, develop the business case, establish an evaluation framework and prepare for operational change. Dedicated customer-success and engineering teams then configure the platform around the organization’s workflows, enabling enterprise deployments in four to six weeks with limited demands on internal staff. The company also uses a performance-based model tied to verified results, including appointments booked, interactions resolved and revenue generated. That structure directly connects Parakeet’s economics to the outcomes its customers are trying to achieve.

Parakeet’s growth comes as healthcare organizations face increasing pressure to improve patient access without adding staff and costs at the same rate. Nearly three in 10 medical groups reported longer new-patient wait times in 2026, even as practices added providers, expanded hours and made other changes to increase access. AI now plays some role in patient visits at 83% of medical groups, up from 71% a year earlier. As adoption grows, healthcare organizations are increasingly evaluating AI based on its ability to improve access, increase capacity and produce measurable financial returns rather than automate an isolated task.

“The Parakeet team brings together deep AI expertise with a proven ability to win major healthcare customers and deliver measurable ROI,” said Rebecca Lynn, Co-Founder and Managing Director at Canvas Ventures. “They’re helping some of the country’s largest specialty groups book more appointments, lower costs and make it easier for patients to access care. We believe the future of patient engagement is one connected, AI-driven experience across every channel. Not a collection of disconnected tools. Parakeet is delivering that today, with clear financial returns for providers and a seamless experience for patients. And they’re just getting started.”

Parakeet will use the Series A financing to expand its technology and team, advance its personalization capabilities, support continued growth with enterprise healthcare organizations and extend the platform across additional specialties and patient-engagement workflows.

About Parakeet Health

Parakeet Health is a conversational agentic platform that automates burdensome patient-access workflows, helping connect patients with booked appointments, reduce administrative burden and support continuity of care. Its platform, powered by large language models (LLMs), supports various patient-experience use cases by managing both inbound and outbound communications at scale.

Founded by an experienced team of healthcare and technology leaders from some of the most innovative companies, Parakeet is backed by Canvas Ventures, Blank Space Ventures, CoFound Partners, StoryHouse Ventures, HMC INQ and many notable individual investors. Visit www.parakeethealth.com for more information.

[email protected]

SOURCE Parakeet Health

Maxwell relocated its headquarters to Salt Lake City, Utah

SALT LAKE CITY, Oct. 1, 2026 — Maxwell Power (“Maxwell”) today announced the successful closing of an investment commitment of $800 million from Fairtide Partners (“Fairtide”) to purchase battery storage and solar power projects. Following investments of $250 million in 2024 and $750 million in June 2026, this latest round increases Fairtide’s total commitment to $1.8 billion for projects developed by Maxwell.

Maxwell will use the capital to help consumers and small businesses lock in energy savings with solar power and battery storage. In 2026, Maxwell has already helped customers secure more than $100 million of future energy savings, providing much-needed relief for Americans struggling with rising prices, including skyrocketing energy costs. 

“Across America, rising rates and aging infrastructure are making energy more expensive and less reliable,” said Dustin Dunaway, Maxwell’s Chief Revenue Officer. “Maxwell’s full-service home solar and battery storage gives homeowners a way to protect themselves from the rising cost of power.” 

At a time when the broader solar industry is under pressure, Maxwell is thriving thanks to its strong financial backing and proven track record. With this latest round of funding from Fairtide, Maxwell will expand the Maxwell Power Plan to new markets, making it easy for more customers to save on energy. 

“Maxwell is an economic force multiplier,” said Nat Kreamer, Fairtide’s founder and lifetime chairman emeritus of the Solar Energy Industries Association (“SEIA”). “Amid rising interest rates and regulatory change, we are helping Maxwell deliver value every day to consumers and channel partners.”

Fulfilling its promise to U.S. Senator John Curtis (R-Utah), who is a champion of affordable domestic renewable energy, Maxwell relocated its headquarters to Salt Lake City, UT from San Diego, CA. Today, the Company’s employees work in the heart of the Hive near the historic stock exchange.

About Maxwell Power

Homeowners and businesses are Powered for Life^™ when they work with Maxwell. We are the power company that guarantees energy and savings to homeowners and small commercial customers. We deploy solar and battery storage systems to customers’ homes, monitor and maintain those systems, and ensure they deliver power. Our customers purchase power on long-term contracts that lock in savings. Since 2018, Maxwell has invested over $1.5 billion to help customers save an estimated $300 million. For more information about us please visit maxwellpower.com

About Fairtide Partners

Fairtide Partners makes infrastructure, tax equity, and private equity investments. The Firm has facilitated the financing of more than $1 billion battery storage and solar energy projects since 2018. Its private equity portfolio includes category-defining companies such as AMP for the waste industry and Highland for fleet vehicle electrification. Fairtide’s managing partners have over 40 years of combined experience as entrepreneurs, executives, investors, and industry-leading policy advocates. For more information about Fairtide please visit fairtidepartners.com

SOURCE Maxwell Power

The firm expands its active ETF roster to 39 with the new fixed income offering

BALTIMORE, Oct. 1, 2026 — T. Rowe Price, a global investment management firm and a leader in retirement, announced today the addition of the T. Rowe Price Dynamic Emerging Markets Bond ETF [Ticker: TDEM]. Designed as a solution for investors seeking to capitalize on opportunities across the entire emerging markets bond universe, the new active fixed income ETF began trading on the NASDAQ today.

The T. Rowe Price Dynamic Emerging Markets Bond ETF is actively managed to deliver a consistent return profile over time, seeking income and capital appreciation by combining bonds across emerging market sovereign, corporate, and local currency markets. It applies the T. Rowe Price Emerging Markets team’s forward-looking approach, deep fundamental research, and cross sector collaboration that informs active top-down allocation decisions. TDEM’s expense ratio is 0.45%.

TDEM is managed by an experienced team of investment professionals:

• Leonard Kwan, CFA^® – Portfolio manager of the Dynamic Emerging Markets Bond strategy and co-portfolio manager of the Asia Credit Bond strategy, with 29 years of investment experience, including 12 at T. Rowe Price.
• Samy Muaddi, CFA^® – Head of Emerging Markets for the Fixed Income division; portfolio manager for the firm’s Emerging Markets Bond strategy and co-portfolio manager of the Global High Income strategy, with 20 years of investment experience at T. Rowe Price.
• Richard Hall – Portfolio manager of the Emerging Markets Bond Strategy, with 19 years of investment experience, 14 of which have been at T. Rowe Price.

With today’s launch, the firm has brought nine active ETFs to market in 2026. The roster of actively managed ETFs now totals 39, spanning fixed income, equity, multi-asset, digital assets, and thematic strategies. The ETFs are supported by the rigorous fundamental research capabilities of T. Rowe Price investment analysts and portfolio managers, who engage in asking better questions, as they strive to deliver better investment outcomes for clients. 

QUOTES: 

Leonard Kwan, Dynamic Emerging Markets Bond ETF Portfolio Manager
“The complexities of emerging market investing requires active management to navigate divergent growth, inflation, and currency trends. Backed by over 30 years of emerging markets expertise, TDEM offers an innovative approach designed to deliver high yields and dynamically capture relative value opportunities. It reflects our commitment to providing investors with differentiated, high-conviction access to actively managed fixed income.”

Tim Coyne, Global Head of ETFs
“T. Rowe Price Dynamic Emerging Markets Bond ETF gives investors access to an actively managed, flexible fixed income strategy designed to navigate the breadth and complexity of emerging markets debt. This is an asset class which, in our view, requires active management that’s grounded in deep fundamental research. TDEM offers a yield-focused building block that can help investors diversify their portfolios.”

ABOUT T. ROWE PRICE

T. Rowe Price (NASDAQ-GS: TROW) is a leading global asset management firm, entrusted with managing $1.90 trillion in client assets as of August 31, 2026, about two-thirds of which are retirement-related. Renowned for nearly 90 years of investment excellence, retirement leadership, and independent proprietary research, the firm leverages its longstanding expertise to ask better questions that can drive better investment decisions. Built on a culture of integrity and prioritizing client interests, T. Rowe Price empowers millions of investors worldwide to thrive amid evolving markets.
Visit troweprice.com/newsroom for news and public policy commentary.

Consider the investment objectives, risks, and charges and expenses carefully before investing. For a prospectus or, if available, a summary prospectus containing this and other information visit troweprice.com. Read it carefully.

ETFs are bought and sold at market prices, not net asset value (NAV). Investors generally incur the cost of the spread between the prices at which shares are bought and sold. Buying and selling shares may result in brokerage commissions which will reduce returns.

SOURCE T. Rowe Price Group

Die Finanzierung dient der Ausweitung der Produktion von OSCPs ITAR-freien photonischen IMUs in Montreal, da die Nachfrage nach Navigationslösungen steigt, die auch bei gestörtem GNSS-Signal funktionieren.

MONTRÉAL, 1. Oktober 2026 — OSCPS Motion Sensing Inc., firmierend unter dem Namen OSCP, gab heute bekannt, dass es eine Serie-A-Finanzierungsrunde unter der Führung von New Science Ventures und unter Beteiligung von Emerging Ventures sowie 2050 Capital abgeschlossen hat. Somu Subramaniam, Gründer und geschäftsführender Gesellschafter von New Science Ventures, ist dem Vorstand von OSCP beigetreten.

Die photonischen Gyroskope und Inertialsensoren (IMUs) von OSCP sind für Plattformen konzipiert, die auch dann navigationsfähig bleiben müssen, wenn GNSS-Signale gestört oder manipuliert werden oder nicht verfügbar sind – ein Problem, das mittlerweile weit über erklärte Konfliktzonen hinausreicht.

Das Unternehmen wird die Finanzmittel nutzen, um die Produktion in Montréal auszuweiten, seine Entwicklungs- und Vertriebsteams zu vergrößern und seine nächste Generation photonischer Trägheitssensoren auf den Markt zu bringen.

„Der Verlust des Satellitensignals war früher ein Problem auf dem Schlachtfeld. Heute tritt er über Flughäfen und Schifffahrtsrouten auf”, sagte Kazem Zandi, Gründer und Geschäftsführer von OSCP. „Kunden wollen eine Navigation, auf die sie sich verlassen können, wenn GNSS ausfällt, und sie wollen, dass sie ITAR-frei ist. Diese Finanzierungsrunde ermöglicht es uns, hier mehr davon zu bauen – und das schneller.”

„Wir freuen uns sehr darauf, dem Team von OSCP beizutreten, um die weltweit besten IMUs in Bezug auf Navigationsleistung, Größe und Kosten zu entwickeln. Diese IMUs haben das Potenzial, das Paradigma der autonomen Navigation in einer Vielzahl von Anwendungen im Verteidigungs- und Transportsektor grundlegend zu verändern”, sagte Somu Subramaniam, Gründer und geschäftsführender Gesellschafter von New Science Ventures.

Seit Abschluss der Finanzierungsrunde im August hat OSCP „NavigationGate” eingeführt, ein Trägheitsnavigationssystem für Plattformen, die das Satellitensignal verlieren. Außerdem hat das Unternehmen die Unterstützung für ArduPilot sowie einen Open-Source-ROS 2-Treiber für seine MK2 IMU-Produktfamilie hinzugefügt und sich als Lieferant für den „Defence Drone Initiative Marketplace” Kanadas qualifiziert. Weitere Informationen finden Sie unter oscp.com.

INFORMATIONEN ZU OSCP

OSCPS Motion Sensing Inc., firmierend unter dem Namen OSCP, entwickelt und fertigt photonische Gyroskope und Trägheitsmesseinheiten. Das 2015 gegründete Unternehmen mit Sitz in Montréal, Québec, entwickelt Trägheitssensoren, die photonische Genauigkeit auf taktischem Niveau bei Größe, Gewicht, Leistungsaufnahme und Kosten von MEMS bieten – für die Navigation in Situationen, in denen GNSS gestört, beeinträchtigt oder nicht verfügbar ist. Die Kunden des Unternehmens sind in den Bereichen Raumfahrt, Verteidigung, Schifffahrt und Unterwassertechnik, Schienenverkehr, Robotik sowie autonome Bodensysteme tätig. OSCP-Produkte werden in Kanada hergestellt und unterliegen nicht den ITAR-Bestimmungen.

INFORMATIONEN ZU NEW SCIENCE VENTURES

New Science Ventures ist eine Risikokapitalgesellschaft, die in Unternehmen investiert, die neuartige wissenschaftliche Ansätze in den Bereichen Informationstechnologie und Biowissenschaften verfolgen. Das 2004 gegründete Unternehmen mit Niederlassungen in Greenwich, Connecticut, und London verwaltet ein Vermögen von mehr als 1 Milliarde US-Dollar, basierend auf dem ursprünglich zugesagten Kapital. Weitere Informationen finden Sie unter newscienceventures.com.

Pressekontakt: [email protected]

Saluda Grade leads round; Funding to grow Homeward’s proptech financial solutions and platform

AUSTIN, Texas, Oct. 1, 2026 — Homeward, a leader in cash-backed real estate financing solutions, today announced $120 million in equity financing and $330 million in asset-backed debt facilities. The new capital will expand Homeward’s cash offer and bridge financing solutions, enhance the technology powering its integrated home buying and selling platform, and accelerate growth nationwide across the 48 contiguous states.

More than two million licensed real estate professionals guide buyers and sellers through home transactions every year. In today’s market, homes can take longer to sell, making it harder for homeowners to move when they want to and for agents to keep transactions on track. Homeward helps address these challenges with technology-backed financing solutions that remove home-sale contingencies, provide fast access to home equity, and strengthen purchasing power.

“Guidance and expertise from trusted real estate agents will always be at the center of every successful home transaction,” said Tim Heyl, founder and CEO of Homeward. “We’re agents ourselves, so we built Homeward to help fellow agents solve the real problems their clients face every day. This investment allows us to expand our cash offer and bridge financing solutions, helping agents win more business, deliver a better client experience and close more deals.”

Led by Saluda Grade, an alternative investment firm specializing in asset-backed credit, alongside Continental General Insurance Company, Citi Ventures, Magnetar, Harmony Partners, Norwest, Adams Street Partners, LiveOak Ventures, Parker89, Era Ventures, Javelin Venture Partners, and others, the $120 million series D investment builds on Homeward’s differentiated approach to seamless buying and selling. The $330 million asset-backed debt facility will be used to fund more home transactions.

“Homeward is working to solve a financing problem that arises at a consequential moment for homeowners and their agents,” said Ryan Craft, founder and CEO of Saluda Grade. “We believe Tim and his leadership team have extensive experience in this market and have made commendable progress in proving their operating model. We are pleased to support this exceptional team and are enthusiastic about the opportunity this asset class presents.”

Homeward offers a suite of cash offer and bridge financing opportunities:

• Buy Before You Sell gives homeowners the convenience to purchase their next home before selling their current one through short-term bridge financing and a guaranteed backup offer that removes the home sale contingency.
• Cash Offer provides homeowners with the speed and certainty of a cash sale while allowing them to participate in the upside when the home is later resold.
• Buy with Cash enables buyers to make competitive cash-backed offers and then refinance into a traditional mortgage after closing.

“Every transaction presents a different challenge,” said Andrew Franklin, CEO of the Franklin Team at eXp Realty. “We’ve completed dozens of transactions with Homeward because their cash offer and bridge financing solutions give our agents the flexibility to solve problems, keep deals together and ultimately achieve their goals.”

Homeward’s technology platform also brings together Homeward Mortgage and Homeward Title services into an integrated experience for agents and their clients. By connecting every stage of the transaction, Homeward helps streamline the home buying and selling process while giving buyers, sellers and agents greater visibility and confidence from offer through closing.

“In this slow moving market, our clients need to know their existing home will sell in time,” said Chris Marti, CEO of NuMouve at Keller Williams. “Homeward gives us a guaranteed solution, keeping our deals moving. That’s how we win listings and get more referrals.”

Since its founding, Homeward has partnered with more than 25,000 agents and facilitated over four billion dollars in residential real estate transactions.

About Homeward

Homeward helps real estate professionals better serve their clients and grow their business through an integrated suite of home buying, financing, mortgage and title solutions. Homeward helps buyers make more competitive offers, removes common transaction barriers and gives buyers and sellers greater certainty throughout the home buying and selling process. Headquartered in Austin, Texas, Homeward operates in markets across the United States. Learn more at www.homeward.com.

Important Information:

The foregoing statements reflect the experience of certain Homeward business partners. Individual experiences may vary. No compensation was provided for this testimonial. Statements regarding anticipated growth, expansion plans, product benefits, and future business performance are forward-looking statements based on current expectations and assumptions. Actual results may differ materially due to market conditions, regulatory developments, economic factors, and other risks. Homeward’s financing products are subject to eligibility requirements, underwriting criteria, and terms and conditions. References to portfolio investments are provided for illustrative purposes only and should not be assumed to be profitable.

Kelsey Tomascheski, [email protected]

SOURCE Homeward

Fund I seeks to invest in early-stage companies developing technology and services for community health centers and the broader healthcare safety net

LOS ANGELES, Oct. 1, 2026 — Facktor Ventures Management, LLC today announced the launch of Facktor Ventures Fund I LP, an early-stage venture capital fund focused on companies serving community health centers and the broader healthcare safety net. Fund I expects to invest primarily at the Seed and Series A stages in digital health, healthcare software, and healthcare services companies addressing the realities of safety-net care. Target areas include clinical and administrative workflows, workforce capacity, patient access and engagement, revenue cycle performance, care management, behavioral health, data and analytics, and cybersecurity.

Facktor Ventures was established in affiliation with Facktor, a national consulting firm focused on Federally Qualified Health Centers and other safety-net healthcare organizations. Since 2006, Facktor has worked directly with more than 360 health centers, while its network clients collectively reach approximately half of all U.S. health centers.

“Community health centers serve nearly 33 million people yet remain underrepresented in healthcare innovation and venture investing,” said Jay Boyer, General Partner of Facktor Ventures and Facktor’s Managing Partner. “We are building on 20 years of relationships and operating experience to help companies understand this market, develop solutions that work within it, and scale alongside the organizations delivering care.”

Facktor Ventures is being built with the health center movement. The fund’s goal is to be majority owned by health centers and other safety-net organizations, enabling those providers to participate in the value created by healthcare innovation and bring their perspectives directly into the investment ecosystem.

“Companies that succeed in the safety net understand its distinct payment models, regulatory requirements, technology environments, workforce constraints, and patient needs,” said Michael Ceballos, Partner at Facktor Ventures and Senior Director at Facktor. “We seek to help founders design for those realities and give health centers a meaningful voice and stake in the solutions that are built, tested, and scaled.”

About Facktor Ventures
Facktor Ventures is an early-stage venture capital firm that seeks to invest in technology and services that strengthen community health centers and the broader healthcare safety net. Built on Facktor’s national relationships, sector expertise, and 20 years of work in community health, the firm seeks to connect founders with capital, insight, partners, and market access.

About Facktor
Founded in 2006, Facktor is a national healthcare consulting firm advancing community-based care. Its multidisciplinary team advises community health centers, health center-controlled networks, primary care associations, clinically integrated networks, and other mission-driven healthcare organizations. Facktor has worked directly with more than 360 health centers, with additional reach through network clients that collectively serve approximately half of all U.S. health centers. Learn more at facktorhealth.com.

FORWARD-LOOKING STATEMENTS
This press release contains statements that constitute “forward-looking statements,” including with respect to the launch of Fund I and the expected investment objective and strategy Fund I expects to pursue. No assurance can be given that the Fund I will be able to successfully attract the needed investors or that it will find suitable target companies for its investment program. Even if such investments are made, there is no guarantee that any such investment will be profitable. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Facktor. Facktor undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Media Contact
Michael Ceballos
Partner, Facktor Ventures
[email protected]
614.404.8804

SOURCE Facktor Ventures